-
Study aim
-
Investigating the effect of “Hijamat” on acute inhalant intoxication with chlorine gas
-
Design
-
Quasi-experimental clinical trial with the sample of 60 individuals and a simple random allocation method will be used to assign participants to the experimental and control groups
-
Settings and conduct
-
Sampling will be done from patients with inhalant intoxication referring to the Intoxication Emergency Department of Loghman Hospital. After performing the necessary new medicine treatments and obtaining consent and randomization,“Hijamat” will be used as a treatment for the intervention group,only once at the patient’s visit, however the evaluation of patients in both groups will be measured and recorded in three stages, one hour, one week and one month after the intervention.Patients’ signs and symptoms will be investigated and registered through questionnaires, instrumental measurements and examination by three separate physicians, in both groups. Finally, the data will be analyzed using statistical software.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Moderate to severe intoxication.
Age: 2 - 60 years old.
Consent to Hijamat.
No history of previous pulmonary diseases or hypersensitivity syndromes
Not taking any anticoagulants drugs
Not consuming foods such as egg, fish, liver, pickle and dairy products during the last 12 hours.
No having sex, menstruation, severe bleeding or any kind of bleeding within the last 12 hours.
Exclusion criteria:
Not having consent to do Hijamat.
No diseases with pulmonary symptoms during the Evaluation period.
Unwillingness to cooperate in the post-intervention assessment.
-
Intervention groups
-
Inhalant intoxicated patients with chlorine gas
-
Main outcome variables
-
Dyspnea, maximum exhale respiratory flow, blood oxygen saturation level, PR , RR and BP, pulmonary'sounds and other organs signs and symptoms